Legal & General Group
TNXP icon

Legal & General Group’s Tonix Pharmaceuticals TNXP Stock Holding History

Legal & General Group’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.5K Hold
1,053
– – ﹤0.01% 3085
2025
Q4 		$16.4K Buy
1,053
+220
+26% +$4.06K ﹤0.01% 3105
2025
Q3 		$20.1K Buy
833
+144
+21% +$5.34K ﹤0.01% 3030
2025
Q2 		$24.7K Buy
+689
New +$18.1K ﹤0.01% 2921
2022
Q3 		– Hold
0
– -$2K – 3489
2022
Q2 		– Hold
0
– – – 3491
2022
Q1 		– Hold
0
– – – 3432
2021
Q4 		– Hold
0
– – – 3411
2021
Q3 		– Hold
0
– – – 3314
2021
Q2 		– Hold
0
– – – 3151

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Legal & General Group's TNXP Position: Q1 2026 in Review

Legal & General Group held its Tonix Pharmaceuticals (TNXP) position steady in Q1 2026 at 1,053 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3085.

Legal & General Group first reported a position in TNXP in Q2 2025 and has held it in 4 quarters since. The position peaked at $24.7K in Q2 2025. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

  • Legal & General Group held 1,053 shares of Tonix Pharmaceuticals worth $14.5K as of Q1 2026.
  • Legal & General Group left its Tonix Pharmaceuticals share count unchanged in Q1 2026.
  • Tonix Pharmaceuticals made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #3085 holding.
  • Legal & General Group first reported a position in Tonix Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Legal & General Group's Tonix Pharmaceuticals position peaked at $24.7K in Q2 2025.
  • 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.